ICCC

ImmuCell Corporation (ICCC)

About ImmuCell Corporation (ICCC)

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Details

Daily high

$4.63

Daily low

$4.38

Price at open

$4.58

52 Week High

$5.82

52 Week Low

$3.34

Market cap

39.3M

Dividend yield

0.00%

Volume

24,463

Avg. volume

23,607

P/E ratio

-9.08

ImmuCell Corporation News